Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
CADL holding history
Candel Therapeutics, Inc. in every 13F filed by Northpond Ventures, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CADL overviewAll 13F holders of CADLFull Q3 2024 holdings
- Shares (Q3 2024)
- 1,935,215
- Value
- $13.4M
- % of portfolio
- 30.7%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 1,935,215 | $13.4M | 30.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,935,215 | $12.0M | 21.7% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,935,215 | $3.06M | 3.0% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,935,215 | $2.84M | 13.5% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,935,215 | $1.78M | 5.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,935,215 | $2.44M | 4.0% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,935,215 | $2.61M | 1.5% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,935,215 | $3.46M | 1.9% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,935,215 | $6.08M | 4.3% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,935,215 | $6.27M | 6.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,935,215 | $9.85M | 5.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,935,215 | $15.1M | 5.3% | – | No prior filing | Holders |